Home > Insider Trading > Filing (0001127602-23-002745)

Filing Details

Accession Number:: 0001127602-23-002745
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-31 16:28:47
Reporting Period:: 2023-01-27

Accepted Time:: 2023-01-31 16:28:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1531048	Inari Medical Inc.	NARI	Surgical & Medical Instruments & Apparatus (3841)	452902923

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1806426	Thomas Tu	C/O Inari Medical, Inc. 6001 Oak Canyon Irvine CA 92618	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-01-27	10,000	$0.46	95,700	No	4	M	Direct
Common Stock	Disposition	2023-01-27	2,699	$58.32	93,001	No	4	S	Direct
Common Stock	Disposition	2023-01-27	2,130	$59.88	90,871	No	4	S	Direct
Common Stock	Disposition	2023-01-27	700	$60.77	90,171	No	4	S	Direct
Common Stock	Disposition	2023-01-27	3,071	$62.06	87,100	No	4	S	Direct
Common Stock	Disposition	2023-01-27	1,100	$63.31	86,000	No	4	S	Direct
Common Stock	Disposition	2023-01-27	300	$63.94	85,700	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2023-01-27	10,000	$0.00	10,000	$0.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
149,584		2029-04-23	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
This transaction was executed in multiple trades at prices ranging from $58.40 to $59.38 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $59.43 to $60.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $60.44 to $61.34 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $61.57 to $62.56 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $62.83 to $63.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $63.83 to $64.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The balance includes 264 shares acquired under the Company's Employee Stock Purchase Plan.
The option vested with respect to 25% of the underlying shares on April 23, 2020, and vests with respect to the remaining shares in 36 equal monthly installments thereafter.